Related Experiment Videos
Allopurinol-induced toxic epidermal necrolysis
International Journal of Dermatology
|March 1, 1984
Summary
Allopurinol, a gout medication, can cause toxic epidermal necrolysis, a severe skin reaction. This case highlights a rare but serious adverse effect, with the patient surviving this potentially fatal condition.
Area of Science:
- Dermatology
- Pharmacology
- Toxicology
Background:
- Allopurinol is a widely prescribed medication for managing hyperuricemia and gout.
- Severe cutaneous adverse reactions (SCARs) are known, albeit rare, complications of allopurinol therapy.
- Toxic epidermal necrolysis (TEN) is a life-threatening mucocutaneous reaction characterized by widespread epidermal detachment.
Observation:
- An 84-year-old male patient developed an erythematous, itchy rash four days after starting allopurinol.
- Clinical signs suggestive of epidermal separation prompted suspicion of TEN.
- Skin biopsy confirmed the diagnosis of toxic epidermal necrolysis.
Findings:
- This case represents the third documented instance of toxic epidermal necrolysis exclusively linked to allopurinol.
- Unlike previous reports, this patient survived the severe adverse reaction, marking a significant clinical outcome.
- The temporal association between allopurinol initiation and rash onset strongly implicates the drug as the causative agent.
Implications:
- This case underscores the critical need for heightened awareness of allopurinol-induced toxic epidermal necrolysis among healthcare providers.
- Early recognition and prompt drug withdrawal are crucial for improving patient outcomes in TEN.
- Further research into genetic or other predisposing factors for allopurinol-associated TEN may aid in risk stratification and prevention.